Profile picture

Doctor Arzu KALAYCI

Harvard Medical School, Boston (United States of America)
Membership: EACVI Member
Follow
Logo ESC

Contributor content

Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial
Presentation
Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial
Read more
Asymptomatic deep vein thrombosis in acutely ill medical patients: insights from the APEX trial
Presentation
Asymptomatic deep vein thrombosis in acutely ill medical patients: insights from the APEX trial
Read more

ESC 365 is supported by

novartis Explore sponsored resources